Current Diagnosis and Management of Cancer of Unknown Primary Site in Nova Scotia, Canada: Basis for development of clinical practice guidelines

Authors

  • N Power Cancer Care Nova Scotia and Dalhousie University
  • B. Sabo Cancer Care Nova Scotia and Dalhousie University
  • R. Dewar Cancer Care Nova Scotia and Dalhousie University
  • M. Bullock Cancer Care Nova Scotia and Dalhousie University
  • M. MacIntyre Cancer Care Nova Scotia and Dalhousie University
  • A. Padmos Cancer Care Nova Scotia and Dalhousie University
  • A. Casson Cancer Care Nova Scotia and Dalhousie University

DOI:

https://doi.org/10.15273/dmj.Vol31No1.4289

Abstract

Between 1992 and 1999, 1421 cases of cancer of unknown primary site (CUPS) were reported in Nova Scotia (1).  The prognosis for this group of patients was very poor with a mean survival of 5.2 months.  A retrospective study of the diagnostic workup, therapy, response to treatment, and survival for a randomly selected group of CUPS cases from four subsets was completed.  The four subsets analyzed were: adenocarcinoma of varying degrees of differentiation, neoplasms not otherwise specified (NOS), poorly differentiated carcinoma or carcinoma not otherwise specified, and squamous cell carcinoma.  Findings demonstrated variation in clinical practice.  The data suggests that evidence-based and cost-effective guidelines should be developed to standardize diagnostic workup and best treatment options for patients presenting with CUPS.  A standard provincial or national clinical practice guideline for patients with CUPS does not currently exist.  The purpose of this paper is to present a Nova Scotian perspective on CUPS patient care to aid in the formation of a provincial and national, evidence based, and critically appraised practice guideline.

Downloads

How to Cite

Power, N., Sabo, B., Dewar, R., Bullock, M., MacIntyre, M., Padmos, A., & Casson, A. (2003). Current Diagnosis and Management of Cancer of Unknown Primary Site in Nova Scotia, Canada: Basis for development of clinical practice guidelines. DALHOUSIE MEDICAL JOURNAL, 31(1). https://doi.org/10.15273/dmj.Vol31No1.4289

Issue

Vol. 31 No. 1 (2003)

Section

Articles

License

Authors who publish with this journal agree to the following terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).